Skip to content
FolioFact
FolioFact
Q2 2026 7/58 funds filed
Newest stored record
Sign in Sign up

Voss Capital — RNTX

How Voss Capital's position in Rein Therapeutics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held
2
First reported
Q4 2025
Latest value
$5,704,871
Latest weight
0.3%
Peak weight
0.3%
Shares since first
+3.4%

Position Trend

Shares, value, and weight from first report to latest report.

Voss Capital first reported 4,243,969 shares in Q4 2025 and most recently reported 4,388,362 shares in Q1 2026. Portfolio weight peaked at 0.3% in Q1 2026; the low reported weight was 0.3% in Q4 2025.

Since the first report, shares are +3.4% and reported value is +15.9%. Latest move: ADD

Quarter Shares Value % of portfolio Change
Q1 2026 4,388,362 $5,704,871 0.33% ADD
Q4 2025 4,243,969 $4,923,004 0.26% NEW